PRKACG Antikörper (AA 300-349)
Kurzübersicht für PRKACG Antikörper (AA 300-349) (ABIN6753869)
Target
Alle PRKACG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 300-349
-
Spezifität
- Human PRKACG
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human PRKACG (P22612, NP_002723). Percent identity by BLAST analysis: Human, Chimpanzee (100%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS, 2 % sucrose.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short term: 4°C
Long term: -20°C.
-
-
- PRKACG (Protein Kinase, CAMP-Dependent, Catalytic, gamma (PRKACG))
-
Andere Bezeichnung
- PRKACG
-
Hintergrund
-
Name/Gene ID: PRKACG
Subfamily: cAMP
Family: Protein Kinase
Synonyms: PRKACG, KAPG, PKA C-gamma, PKACg, Cgamma -
Gen-ID
- 5568
-
NCBI Accession
- NP_002723
-
Pathways
- AMPK Signaling, Hedgehog Signalweg, Thyroid Hormone Synthesis, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-